Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:11 AM
Ignite Modification Date:
2025-12-25 @ 5:11 AM
NCT ID:
NCT07145827
Eligibility Criteria:
Inclusion Criteria:
* Postmenopausal Female patients (amenorrhea ≥ 12 months).
* Histologically proven (Estrogen-positive) breast cancer.
* Completed all required surgery and/or chemotherapy (if indicated)
* On adjuvant tamoxifen for at least 1 year.
* Accepts to enroll in the study
Exclusion Criteria:
* Refusing to enroll in the study
* Ongoing or History of: endometrial or ovarian malignancy
* Concurrent hormonal therapy that might affect endometrial thickness
* Concurrent Diabetes mellitus in which metformin is prescribed.
* Known hypersensitivity or severe intolerance to metformin
Healthy Volunteers:
False
Sex:
FEMALE
Study:
NCT07145827
Study Brief:
Protocol Section:
NCT07145827